Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 209.02

+3.2%

Nov 10 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SPSEIFERT who wrote (22689)	6/25/1998 10:04:00 AM
From: Henry Niman	Read Replies (3) of 32384

LGND has discovered a new class of compounds that are not analogs of steroids, the natural class of molecules that bind to IRs but have significant side effects. The uploaded abstract indicates that the new compound is effective in treating animal models of prostate cancer but they do not have some of the side effects associated with other anti-androgens (which also are distinct from steroids, but not of the same class that LGND has discovered). Compounds in this class also have anti-progestin activities and I believe that LGND has broad patent protection for such compounds.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next